Epigenetic regulation in the carcinogenesis of cholangiocarcinoma

Nai Jung Chiang, Yan Shen Shan, Wen Chun Hung, Li Tzong Chen

研究成果: Review article

11 引文 (Scopus)

摘要

Cholangiocarcinoma (CCA) is a malignancy arising from the epithelial cells lining the biliary tract. Despite the existence of variation in incidence and etiology worldwide, its incidence is increasing globally in the past few decades. Surgery is the only curative treatment option for a minority of patients presented with early disease; while moderate effective chemotherapy remains the standard care for patients with locally advanced or metastatic diseases. In this article, we briefly review the molecular alterations that have been described in CCAs focusing on the role of epigenetic modification, including promoter methylation inactivation, histone modification and microRNA, in the carcinogenesis and progression of CCAs. This article is part of a Directed Issue entitled: Epigenetics dynamics in development and disease.

原文English
文章編號4649
頁(從 - 到)110-114
頁數5
期刊International Journal of Biochemistry and Cell Biology
67
DOIs
出版狀態Published - 2015 十月 1

指紋

Cholangiocarcinoma
Epigenomics
Carcinogenesis
Histone Code
Methylation
Chemotherapy
Incidence
Biliary Tract
MicroRNAs
Linings
Histones
Surgery
Patient Care
Epithelial Cells
Drug Therapy
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Cell Biology

引用此文

@article{fe57a206df59493f9f425cc22b5edcbb,
title = "Epigenetic regulation in the carcinogenesis of cholangiocarcinoma",
abstract = "Cholangiocarcinoma (CCA) is a malignancy arising from the epithelial cells lining the biliary tract. Despite the existence of variation in incidence and etiology worldwide, its incidence is increasing globally in the past few decades. Surgery is the only curative treatment option for a minority of patients presented with early disease; while moderate effective chemotherapy remains the standard care for patients with locally advanced or metastatic diseases. In this article, we briefly review the molecular alterations that have been described in CCAs focusing on the role of epigenetic modification, including promoter methylation inactivation, histone modification and microRNA, in the carcinogenesis and progression of CCAs. This article is part of a Directed Issue entitled: Epigenetics dynamics in development and disease.",
author = "Chiang, {Nai Jung} and Shan, {Yan Shen} and Hung, {Wen Chun} and Chen, {Li Tzong}",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.biocel.2015.06.012",
language = "English",
volume = "67",
pages = "110--114",
journal = "International Journal of Biochemistry and Cell Biology",
issn = "1357-2725",
publisher = "Elsevier Limited",

}

Epigenetic regulation in the carcinogenesis of cholangiocarcinoma. / Chiang, Nai Jung; Shan, Yan Shen; Hung, Wen Chun; Chen, Li Tzong.

於: International Journal of Biochemistry and Cell Biology, 卷 67, 4649, 01.10.2015, p. 110-114.

研究成果: Review article

TY - JOUR

T1 - Epigenetic regulation in the carcinogenesis of cholangiocarcinoma

AU - Chiang, Nai Jung

AU - Shan, Yan Shen

AU - Hung, Wen Chun

AU - Chen, Li Tzong

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Cholangiocarcinoma (CCA) is a malignancy arising from the epithelial cells lining the biliary tract. Despite the existence of variation in incidence and etiology worldwide, its incidence is increasing globally in the past few decades. Surgery is the only curative treatment option for a minority of patients presented with early disease; while moderate effective chemotherapy remains the standard care for patients with locally advanced or metastatic diseases. In this article, we briefly review the molecular alterations that have been described in CCAs focusing on the role of epigenetic modification, including promoter methylation inactivation, histone modification and microRNA, in the carcinogenesis and progression of CCAs. This article is part of a Directed Issue entitled: Epigenetics dynamics in development and disease.

AB - Cholangiocarcinoma (CCA) is a malignancy arising from the epithelial cells lining the biliary tract. Despite the existence of variation in incidence and etiology worldwide, its incidence is increasing globally in the past few decades. Surgery is the only curative treatment option for a minority of patients presented with early disease; while moderate effective chemotherapy remains the standard care for patients with locally advanced or metastatic diseases. In this article, we briefly review the molecular alterations that have been described in CCAs focusing on the role of epigenetic modification, including promoter methylation inactivation, histone modification and microRNA, in the carcinogenesis and progression of CCAs. This article is part of a Directed Issue entitled: Epigenetics dynamics in development and disease.

UR - http://www.scopus.com/inward/record.url?scp=84940898286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940898286&partnerID=8YFLogxK

U2 - 10.1016/j.biocel.2015.06.012

DO - 10.1016/j.biocel.2015.06.012

M3 - Review article

C2 - 26100596

AN - SCOPUS:84940898286

VL - 67

SP - 110

EP - 114

JO - International Journal of Biochemistry and Cell Biology

JF - International Journal of Biochemistry and Cell Biology

SN - 1357-2725

M1 - 4649

ER -